vs
Axsome Therapeutics, Inc.（AXSM）与OneStream, Inc.（OS）财务数据对比。点击上方公司名可切换其他公司
Axsome Therapeutics, Inc.的季度营收约是OneStream, Inc.的1.2倍（$191.2M vs $163.7M），Axsome Therapeutics, Inc.同比增速更快（57.4% vs 23.6%），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（48.1% vs 21.8%）
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
Blue Stream面向美国佛罗里达州科勒尔斯普林斯、韦斯顿两地的居民及商业客户，提供有线电视、有线固话、数字录像服务，以及最高速率达1G的宽带互联网接入服务，深耕当地通信市场，为用户提供稳定可靠的多元通信解决方案。
AXSM vs OS — 直观对比
营收规模更大
AXSM
是对方的1.2倍
$163.7M
营收增速更快
AXSM
高出33.8%
23.6%
两年增速更快
AXSM
近两年复合增速
21.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $191.2M | $163.7M |
| 净利润 | — | $999.0K |
| 毛利率 | — | 69.8% |
| 营业利润率 | -33.1% | -3.2% |
| 净利率 | — | 0.6% |
| 营收同比 | 57.4% | 23.6% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXSMOS
| Q1 26 | $191.2M | — | ||
| Q4 25 | $196.0M | $163.7M | ||
| Q3 25 | $171.0M | $154.3M | ||
| Q2 25 | $150.0M | $147.6M | ||
| Q1 25 | $121.5M | $136.3M | ||
| Q4 24 | $118.8M | $132.5M | ||
| Q3 24 | $104.8M | $129.1M | ||
| Q2 24 | $87.2M | $117.5M |
净利润AXSMOS
| Q1 26 | — | — | ||
| Q4 25 | $-28.6M | $999.0K | ||
| Q3 25 | $-47.2M | $-8.8M | ||
| Q2 25 | $-48.0M | $-18.4M | ||
| Q1 25 | $-59.4M | $-24.0M | ||
| Q4 24 | $-74.9M | — | ||
| Q3 24 | $-64.6M | $-171.9M | ||
| Q2 24 | $-79.3M | $-7.8M |
毛利率AXSMOS
| Q1 26 | — | — | ||
| Q4 25 | — | 69.8% | ||
| Q3 25 | — | 68.1% | ||
| Q2 25 | — | 68.6% | ||
| Q1 25 | — | 68.0% | ||
| Q4 24 | — | 66.8% | ||
| Q3 24 | — | 50.1% | ||
| Q2 24 | — | 68.5% |
营业利润率AXSMOS
| Q1 26 | -33.1% | — | ||
| Q4 25 | -13.8% | -3.2% | ||
| Q3 25 | -27.0% | -11.3% | ||
| Q2 25 | -24.5% | -21.8% | ||
| Q1 25 | -46.9% | -29.3% | ||
| Q4 24 | -61.1% | -35.8% | ||
| Q3 24 | -59.8% | -197.6% | ||
| Q2 24 | -89.5% | -9.8% |
净利率AXSMOS
| Q1 26 | — | — | ||
| Q4 25 | -14.6% | 0.6% | ||
| Q3 25 | -27.6% | -5.7% | ||
| Q2 25 | -32.0% | -12.5% | ||
| Q1 25 | -48.9% | -17.6% | ||
| Q4 24 | -63.1% | — | ||
| Q3 24 | -61.7% | -133.1% | ||
| Q2 24 | -91.0% | -6.7% |
每股收益（稀释后）AXSMOS
| Q1 26 | — | — | ||
| Q4 25 | $-0.55 | — | ||
| Q3 25 | $-0.94 | — | ||
| Q2 25 | $-0.97 | — | ||
| Q1 25 | $-1.22 | — | ||
| Q4 24 | $-1.54 | — | ||
| Q3 24 | $-1.34 | $-1.06 | ||
| Q2 24 | $-1.67 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $305.1M | $693.6M |
| 总债务越低越好 | $70.0M | — |
| 股东权益账面价值 | — | $504.7M |
| 总资产 | $713.6M | $1.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AXSMOS
| Q1 26 | $305.1M | — | ||
| Q4 25 | $322.9M | $693.6M | ||
| Q3 25 | $325.3M | $653.9M | ||
| Q2 25 | $303.0M | $652.1M | ||
| Q1 25 | $300.9M | $593.9M | ||
| Q4 24 | $315.4M | $544.2M | ||
| Q3 24 | $327.3M | $495.5M | ||
| Q2 24 | $315.7M | $140.5M |
总债务AXSMOS
| Q1 26 | $70.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益AXSMOS
| Q1 26 | — | — | ||
| Q4 25 | $88.3M | $504.7M | ||
| Q3 25 | $73.7M | $472.1M | ||
| Q2 25 | $73.1M | $458.2M | ||
| Q1 25 | $53.2M | $412.9M | ||
| Q4 24 | $57.0M | $386.2M | ||
| Q3 24 | $92.9M | $458.2M | ||
| Q2 24 | $102.9M | $97.5M |
总资产AXSMOS
| Q1 26 | $713.6M | — | ||
| Q4 25 | $689.8M | $1.0B | ||
| Q3 25 | $669.3M | $949.4M | ||
| Q2 25 | $639.8M | $910.5M | ||
| Q1 25 | $596.7M | $867.3M | ||
| Q4 24 | $568.5M | $823.2M | ||
| Q3 24 | $561.5M | $750.1M | ||
| Q2 24 | $548.2M | $379.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.8M |
| 自由现金流经营现金流 - 资本支出 | — | $25.6M |
| 自由现金流率自由现金流/营收 | — | 15.7% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | — | 25.79× |
| 过去12个月自由现金流最近4个季度 | — | $95.6M |
8季度趋势，按日历期对齐
经营现金流AXSMOS
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $25.8M | ||
| Q3 25 | $1.0M | $5.0M | ||
| Q2 25 | $-32.4M | $29.7M | ||
| Q1 25 | $-43.4M | $36.2M | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $-18.6M | $2.4M | ||
| Q2 24 | $-30.1M | $8.1M |
自由现金流AXSMOS
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $25.6M | ||
| Q3 25 | $988.0K | $4.8M | ||
| Q2 25 | $-32.4M | $29.4M | ||
| Q1 25 | $-43.7M | $35.8M | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $-18.7M | $1.3M | ||
| Q2 24 | $-30.2M | $7.7M |
自由现金流率AXSMOS
| Q1 26 | — | — | ||
| Q4 25 | -9.6% | 15.7% | ||
| Q3 25 | 0.6% | 3.1% | ||
| Q2 25 | -21.6% | 19.9% | ||
| Q1 25 | -36.0% | 26.3% | ||
| Q4 24 | -22.1% | — | ||
| Q3 24 | -17.9% | 1.0% | ||
| Q2 24 | -34.6% | 6.6% |
资本支出强度AXSMOS
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.3% | 0.3% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.1% | 0.8% | ||
| Q2 24 | 0.1% | 0.3% |
现金转化率AXSMOS
| Q1 26 | — | — | ||
| Q4 25 | — | 25.79× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXSM
| Product sales, net | $189.4M | 99% |
| Royalty revenue and milestone revenue | $1.8M | 1% |
OS
| Subscription And Circulation | $150.3M | 92% |
| Professional Services And Other | $9.4M | 6% |
| License | $4.0M | 2% |
